Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/46875
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rashid H.N. | - |
dc.contributor.author | Michail M. | - |
dc.contributor.author | Ramnarain J. | - |
dc.contributor.author | Nasis A. | - |
dc.contributor.author | Nicholls S.J. | - |
dc.contributor.author | Cameron J.D. | - |
dc.contributor.author | Gooley R.P. | - |
dc.date.accessioned | 2022-04-04T06:11:05Z | - |
dc.date.available | 2022-04-04T06:11:05Z | - |
dc.date.issued | 2022-03-06 | en |
dc.identifier.citation | Journal of Cardiovascular Computed Tomography. 16(2) (pp 168-173), 2022. Date of Publication: 01 Mar 2022. | - |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/46875 | - |
dc.description.abstract | Background: Hypo-attenuated leaflet thickening (HALT) may occur following transcatheter aortic valve replacement (TAVR), however, it remains unclear if HALT is a predictor of haemodynamic valve deterioration (HVD). Aim(s): To determine the impact of HALT on the occurrence of HVD. Method(s): We prospectively evaluated 186 patients for the presence of HALT at a median of 6 weeks following TAVR (Interquartile-range [IQR] 4-12 weeks). HALT depth and area were measured. HVD encompassed any of the following: mean gradient >=20 mmHg with an increase in gradient >=10 mmHg from baseline, Doppler velocity index reduction >=0.1 or new moderate-to-severe valvular regurgitation. Routine echocardiograms at discharge, one month and annually, were assessed by echo-cardiologists that were blinded to the HALT status. Result(s): LT prevalence was 17.7% (33/186). HVD was present in 8.6% (16/186) at a median follow-up of 2 years (IQR 1-3); two required valve re-intervention and five required anticoagulation. HALT was the only independent predictor of HVD on multivariate analysis (OR 33.3, 95%CI 7.4-125). Patients with HALT were more likely to develop HVD, require repeat valve intervention and have higher trans-valvular gradients at up to 3-year follow-up. Patients with HALT had a median cumulative thickness of 2.9 mm (IQR 1.9-4.7) and area of 64.2 mm2 (IQR 40.9-91.6). Thresholds for HALT in predicting HVD were a cumulative depth of 2.4 mm (Specificity 94.1%, Sensitivity 75.0%, AUC = 0.87) and cumulative area of 28 mm2 (Specificity 92.2%, Sensitivity 81.3%, AUC = 0.86). Conclusion(s): HALT is an independent predictor of HVD, which exhibits specific depth and area thresholds to predict HVD. CT following TAVR may determine patients at risk of HVD.Copyright © 2021 | - |
dc.publisher | Elsevier Inc. | - |
dc.relation.ispartof | Journal of Cardiovascular Computed Tomography | - |
dc.subject.mesh | aged | - |
dc.subject.mesh | anticoagulant therapy | - |
dc.subject.mesh | body mass | - |
dc.subject.mesh | cerebrovascular accident | - |
dc.subject.mesh | chronic obstructive lung disease | - |
dc.subject.mesh | computer assisted tomography | - |
dc.subject.mesh | coronary artery bypass graft | - |
dc.subject.mesh | echocardiography | - |
dc.subject.mesh | four dimensional computed tomography | - |
dc.subject.mesh | heart cycle | - |
dc.subject.mesh | heart failure | - |
dc.subject.mesh | percutaneous coronary intervention | - |
dc.subject.mesh | practice guideline | - |
dc.subject.mesh | surface property | - |
dc.subject.mesh | transcatheter aortic valve implantation | - |
dc.subject.mesh | transient ischemic attack | - |
dc.subject.mesh | valve deterioration/co acetylsalicylic acid/pv [Special Situation for Pharmacovigilance] | - |
dc.subject.mesh | clopidogrel/pv [Special Situation for Pharmacovigilance] | - |
dc.subject.mesh | heparin/ia [Intraarterial Drug Administration] | - |
dc.subject.mesh | heparin/pv [Special Situation for Pharmacovigilance] | - |
dc.subject.mesh | iohexol/pv [Special Situation for Pharmacovigilance] | - |
dc.subject.mesh | protamine/pv [Special Situation for Pharmacovigilance] | - |
dc.subject.mesh | aortic valve prosthesis | - |
dc.subject.mesh | computed tomography scanner | - |
dc.subject.mesh | heart valve bioprosthesis | - |
dc.subject.mesh | percutaneous aortic valve | - |
dc.subject.mesh | percutaneous aortic valve bioprosthesis | - |
dc.subject.mesh | haemodynamic valve deterioration/co hypoattenuated leaflet thickening/co CoreValve/Evolut | - |
dc.title | The impact of hypo-attenuated leaflet thickening on haemodynamic valve deterioration following transcatheter aortic valve replacement. | - |
dc.type | Article | - |
dc.identifier.affiliation | Cardiology (MonashHeart) | - |
dc.identifier.affiliation | Respiratory and Sleep Medicine | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1016/j.jcct.2021.11.013 | - |
dc.publisher.place | United States | - |
dc.identifier.pubmedid | 34852974 [https://www.ncbi.nlm.nih.gov/pubmed/?term=34852974] | - |
dc.identifier.institution | (Rashid, Ramnarain, Nasis, Nicholls, Cameron, Gooley) Monash Heart, Monash Health and Monash Cardiovascular Research Centre, Monash University, Australia | - |
dc.identifier.institution | (Michail) Sussex Cardiac Centre, University Hospital Sussex NHS Trust, Brighton, United Kingdom | - |
dc.description.grant | Organization: (NHMRC) *National Health and Medical Research Council* Organization No: 501100000925 Country: Australia | - |
dc.description.grant | Organization: (RACP) *Royal Australasian College of Physicians* Organization No: 501100001232 Country: Australia | - |
dc.description.grant | Organization: *National Heart Foundation of Australia* Organization No: 501100001030 Country: Australia | - |
dc.description.grant | Organization: *National Heart Foundation of Australia* Organization No: 501100001030 Country: Australia | - |
dc.identifier.affiliationmh | (Rashid, Ramnarain, Nasis, Nicholls, Cameron, Gooley) Monash Heart, Monash Health and Monash Cardiovascular Research Centre, Monash University, Australia | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Cardiology (MonashHeart & Victorian Heart Institute) | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.